Back to results
US 12,629,406 B2Granted
Alterations in endothelin receptors following hemorrhage and resuscitation by centhaquin
AssigneesMidwestern University, Pharmazz, Inc.
InventorsAnil Gulati, Manish Lavhale, Bhawna Katia, Abhishek Kumar Singh
Life of this patent
Estimating the term…
Abstract
The present disclosure is related to methods and compositions for treating or preventing kidney injury or failure, comprising administering an endothelin B (ETB) receptor agonist and/or an α2 adrenergic agent.
Claims15
A method of treating an individual suffering acute kidney function decline comprising administering to the individual a therapeutically effective amount of a composition comprising centhaquin or a salt thereof.
Dependencies are inferred from the claim text.